Debating Euthanasia and Physician-Assisted Death in People with Psychiatric Disorders

• Published in: Current psychiatry reports 2022-06, Vol.24 (6), p.325-335
• Main Authors: Grassi, Luigi, Folesani, Federica, Marella, Marco, Tiberto, Elisa, Riba, Michelle B., Bortolotti, Lisa, Toffanin, Tommaso, Palagini, Laura, Belvederi Murri, Martino, Biancosino, Bruno, Ferrara, Maria, Caruso, Rosangela
• Format: Article
• Language: English
• Subjects: Aged; Assisted suicide; Canada; Complex Medical-Psychiatric Issues (M Riba; Complex Medical-Psychiatric Issues (M Riba, Section Editor); Euthanasia; Humans; Medicine; Medicine & Public Health; Mental disorders; Mental Disorders - psychology; Physicians; Psychiatry; Psychotic Disorders; Section Editor; Suicide, Assisted - psychology; Topical Collection on Complex Medical-Psychiatric Issues
• ISSN: 1523-3812; 1535-1645; 1535-1645
• DOI: 10.1007/s11920-022-01339-y

Purpose of Review Over the last 30 years, medical assistance in dying (MAiD) including euthanasia (EU) and physician-assisted death (or suicide, PAS) has become the center of a large debate, particularly when these practices have involved people with psychiatric illness, including resistant depression, schizophrenia, personality, or other severe psychiatric disorders. We performed a review utilizing several databases, and by including the most relevant studies in full journal articles investigating the problem of MAiD in patients with psychiatric disorders but not in physical terminal conditions (non-terminal, MAiD-NT). Recent Findings Literature has shown that a small percentage of people with psychiatric disorders died by MAiD-NT in comparison with patients with somatic diseases in terminal clinical conditions (e.g., cancer, AIDS). However, the problem in the field is complex and not solved yet as confirmed by the fact that only a few countries (e.g., the Netherlands, Belgium, Luxemburg) have legalized MAiD-NT for patients with psychiatric disorders, while most have maintained the practices accessible only to people with somatic disease in a terminal phase. Also, how to make objective the criterion of irremediability of a mental disorder; how to balance suicide prevention with assisted suicide; how to avoid the risk of progressively including in requests for MAiD-NT vulnerable segments of the population, such as minors, elderly, or people with dementia, in a productive-oriented society, are some of the critical points to be discussed. Summary The application of MAiD-NT in people with psychiatric disorders should be further explored to prevent end-of-life rights from contradicting the principles of recovery-oriented care.